People: Atara Biotherapeutics Inc (ATRA.OQ)
Dr. Beth C. Seidenberg, M.D. is an Independent Director of the Company. Dr. Seidenberg is a General Partner at Kleiner Perkins Caufield & Byers, a venture capital firm, where she has primarily focused on life sciences investing since May 2005. Dr. Seidenberg was previously the Senior Vice President, Head of Global Development and Chief Medical Officer at Amgen, Inc., a biotechnology company. In addition, Dr. Seidenberg was a senior executive in research and development at Bristol Myers Squibb Company, a biopharmaceutical company, and Merck. Dr. Seidenberg received a B.S. from Barnard College and an M.D. from the University of Miami School of Medicine and completed her post-graduate training at The Johns Hopkins University, George Washington University and the National Institutes of Health. Dr. Seidenberg serves on the board of directors of TESARO and Epizyme, Inc.
|Total Annual Compensation, USD||50,000|
|Restricted Stock Award, USD||96,150|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||176,789|
|Fiscal Year Total, USD||322,939|